Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Mudan Granules
- Development stage
- Phase 1
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Mudan Granules are a traditional Chinese medicine used to treat diabetic peripheral neuropathy. They are composed of several herbs, including **Astragalus membranaceus** (黄芪), **Vinegar-processed Corydalis yanhusuo** (醋制延胡索), **Panax notoginseng** (三七), **Red Peony** (赤芍), **Salvia miltiorrhiza** (丹参), **Szechuan Lovage** (川芎), **Safflower** (红花), **Strychnos nux-vomica** (苏木), and **Caulis Lonicerae** (鸡血藤). The granules work by tonifying Qi, activating blood circulation, and relieving pain. They are used to alleviate symptoms such as numbness, pain, and abnormal sensations in the limbs and torso, often associated with diabetic neuropathy.
- Brand names
- Mudan Granule
- Other names
- 木丹颗粒
Beyond the preview
Go deeper on Mudan Granules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Mudan Granules.